Search

Your search keyword '"Kwak, Jae‐Yong"' showing total 14 results
Start Over Author "Kwak, Jae‐Yong" Journal annals of hematology
14 results on '"Kwak, Jae‐Yong"'

3. Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study

Author

Kim, Jin Seok, Yoon, Dok Hyun, Park, Seonyang, Yoon, Sung-Soo, Cho, Seok-Goo, Min, Chang-Ki, Lee, Je-Jung, Yang, Deok-Hwan, Kwak, Jae-Yong, Eom, Hyeon-Seok, Kim, Won Seog, Kim, Hawk, Do, Young Rok, Moon, Joon Ho, Lee, Jihye, and Suh, Cheolwon

Published
2016
Full Text
View/download PDF

6. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study

Author

Oh, Sukjoong, Koo, Dong Hoe, Kwon, Min-Jung, Kim, Kihyun, Suh, Cheolwon, Min, Chang-Ki, Yoon, Sung-Soo, Shin, Ho-Jin, Jo, Deog-Yeon, Kwak, Jae-Yong, Kim, Jin Seok, Sohn, Sang Kyun, Joo, Young-Don, Eom, Hyeon-Seok, Kim, Sung-Hyun, Kim, Yang Soo, Kim, ChulSoo, Mun, Yeung-Chul, Kim, Hawk, Lee, Dong Soon, Lee, Jae Hoon, and the Korean Multiple Myeloma Working Party (KMMWP)

Published
2014
Full Text
View/download PDF

7. Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients

Author

Kim, Kihyun, Kim, Seok Jin, Voelter, Verena, Suh, Cheolwon, Yoon, Sung-Soo, Lee, Je-Jung, Kwak, Jae-Yong, Ryoo, Hun-Mo, Kim, Yang Soo, Moon, Joon Ho, Park, Seong Kyu, Kim, Sung-Hyun, Mun, Yeung-Chul, Kim, Jin Seok, Eom, Hyeon-Seok, Jo, Deog-Yeon, Jun, Hyun Jung, Kim, Ki-Hwan, Lee, Jeong-Ok, Lee, Jae Hoon, Min, Chang-Ki, and Korean Multiple Myeloma Working Party (KMMWP)

Published
2014
Full Text
View/download PDF

10. Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation

Author

Kim, Ji-Won, Kim, Byung-Su, Bang, Soo-Mee, Kim, Inho, Kim, Dong Hwan, Kim, Won Seog, Yang, Deok-Hwan, Lee, Je-Jung, Lee, Je-Hwan, Kim, Jin Seok, Sohn, Sang-Kyun, Yhim, Ho-Young, Kwak, Jae-Yong, Yoon, Sung-Soo, Lee, Jong Seok, Park, Seonyang, Kim, Byoung Kook, and on behalf of the Korean Society of Blood and Marrow Transplantation

Published
2011
Full Text
View/download PDF

11. Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas

Author

Ahn, Seo-Yeon, primary, Jung, Seung-Yeon, additional, Jung, Sung-Hoon, additional, Ahn, Jae-Sook, additional, Lee, Je-Jung, additional, Kim, Hyeoung-Joon, additional, Kang, Sae-Ryung, additional, Han, Yeon-Hee, additional, Kwak, Jae-Yong, additional, Yhim, Ho-Young, additional, and Yang, Deok-Hwan, additional

Published
2019
Full Text
View/download PDF

12. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation

Author

Jeong, Seong Hyun, primary, Moon, Joon Ho, additional, Kim, Jin Seok, additional, Yang, Deok-Hwan, additional, Park, Yong, additional, Cho, Seok Goo, additional, Kwak, Jae-Yong, additional, Eom, Hyeon Seok, additional, Won, Jong Ho, additional, Hong, Jun Shik, additional, Oh, Sung Yong, additional, Lee, Ho Sup, additional, and Kim, Seok Jin, additional

Published
2014
Full Text
View/download PDF

13. Clinical features and outcomes of Hodgkin’s lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)

Author

Won, Young-Woong, primary, Kwon, Jung Hye, additional, Lee, Soon Il, additional, Oh, Sung Yong, additional, Kim, Won Seog, additional, Kim, Seok Jin, additional, Won, Jong-Ho, additional, Kim, Kyoung Ha, additional, Park, Seong Kyu, additional, Kim, Jin Seok, additional, Suh, Cheolwon, additional, Yoon, Dok Hyun, additional, Park, Joon Seong, additional, Kim, Min Kyoung, additional, Kim, Hawk, additional, Kang, Hye Jin, additional, Mun, Yeung-Chul, additional, Kwak, Jae-Yong, additional, Kim, Hyo Jung, additional, and Eom, Hyeon-Seok, additional

Published
2011
Full Text
View/download PDF

14. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.

Author

Oh, Sukjoong, Koo, Dong Hoe, Kwon, Min-Jung, Kim, Kihyun, Suh, Cheolwon, Min, Chang-Ki, Yoon, Sung-Soo, Shin, Ho-Jin, Jo, Deog-Yeon, Kwak, Jae-Yong, Kim, Jin Seok, Sohn, Sang Kyun, Joo, Young-Don, Eom, Hyeon-Seok, Kim, Sung-Hyun, Kim, Yang Soo, Kim, ChulSoo, Mun, Yeung-Chul, Kim, Hawk, and Lee, Dong Soon

Abstract

This study was designed to evaluate the prevalence of chromosomal abnormalities and to identify the specific abnormalities associated with poor prognosis. A total of 2,474 patients whose conventional cytogenetics were available at the time of diagnosis were evaluated via a nationwide registry. Normal metaphase cytogenetics was observed in 2,012 patients (81.3%). Among the 462 patients with chromosomal abnormalities, there were 161 (34.8%) patients with hyperdiploidy, 197 (42.6%) with pseudodiploidy, 79 (17.1%) with hypodiploidy, and 25 (5.5%) with near-tetraploidy. Deletion 13 (¿13) in metaphase was observed in 167 patients (6.8%). Fluorescent in situ hybridization (FISH) was carried out in 967 patients (39.1%), and 66 (13.7%) out of 482 and 63 (10.3%) out of 611 patients were positive for t(4;14) and del(17p), respectively. With a median follow-up duration of 25.1 months, the median overall survival (OS) was 51.2 months (95% confidence interval, 46.5-55.9 months). In univariate analysis, the following four chromosomal abnormalities were significantly associated with a poor survival outcome: ¿13, hypodiploidy, del(13q) in FISH, and del(17p) in FISH. In the subsequent multivariate analysis, in which del(13q) and del(17p) in FISH were excluded due to a relatively low number of patients, ¿13 and hypodiploid status were independently associated with a poor survival outcome after adjusting for important clinical factors, including age, sex, performance, beta2-microglobulin, albumin, and lactate dehydrogenase (LDH). Using conventional metaphase cytogenetics, we confirmed that both ¿13 and hypodiploid status were robust poor prognostic factors. The metaphase karyotyping should remain the primary cytogenetic tool and an essential investigation for risk stratification in newly diagnosed multiple myeloma patients. [ABSTRACT FROM AUTHOR]

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results